HARRISON CARTER: Open Payments
NPI 1043221492 · ALMA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 68 payments from 19 companies in 2025. Trend: 2023 $1,489 · 2024 $1,348 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $203 |
| ABBVIE INC. | 11 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $138 |
| SANOFI-AVENTIS U.S. LLC | 6 | $103 |
| Novo Nordisk Inc | 6 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $87 |
| Lilly USA, LLC | 4 | $73 |
| Antares Pharma, Inc. | 3 | $60 |
| Dexcom, Inc. | 3 | $48 |
| Amgen Inc. | 2 | $31 |
Products named: VRAYLAR, Kerendia, AIRSUPRA, TZIELD, GEMTESA, FARXIGA, XYOSTED, MOUNJARO.
Industry payments across GA — which companies pay providers there.
